Spectrum and functional validation of PSMB5 mutations in multiple myeloma. [electronic resource]
Producer: 20190520Description: 447-456 p. digitalISSN:- 1476-5551
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- genetics
- Boron Compounds -- administration & dosage
- Bortezomib -- administration & dosage
- Cohort Studies
- Drug Resistance, Neoplasm -- genetics
- Female
- Follow-Up Studies
- Gene Expression Regulation, Neoplastic
- Glycine -- administration & dosage
- Humans
- Male
- Middle Aged
- Multiple Myeloma -- drug therapy
- Mutation
- Neoplasm Recurrence, Local -- drug therapy
- Oligopeptides -- administration & dosage
- Prognosis
- Proteasome Endopeptidase Complex -- drug effects
- Survival Rate
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.